Haleon PLC closed 7.49% short of its 52-week high of £4.18, which the company achieved on March 4th.

In this article, we are going to take a look at where Haleon plc (NYSE:HLN) stands against the other pharma stocks. Healthcare, which includes numerous businesses that offer patient care ...

Arrowstreet Capital Limited Partnership bought a new stake in shares of Haleon plc (NYSE:HLN – Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and ...

Shares of NYSE:HLN opened at $10.22 on Monday. The business has a fifty day simple moving average of $10.09 and a 200 day simple moving average of $9.80. Haleon has a 12-month low of $8.12 and a ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Canada Soccer and Haleon Canada announced a new multi-year partnership committed to promoting health and wellness on and off ...

Haleon PLC closed 10.34% below its 52-week high of £4.18, which the company achieved on March 4th.

In trading on Monday, shares of Haleon plc (Symbol: HLN) crossed below their 200 day moving average of $9.72, changing hands as low as $9.19 per share. Haleon plc shares are currently trading down ...

British consumer healthcare group Haleon on Tuesday said it gained full control of its Chinese joint venture after acquiring ...

In a report released today, Cedric Besnard from Citi maintained a Buy rating on Haleon PLC (HLN – Research Report), with a price target of ...

In a report released today, Cedric Besnard from Citi maintained a Buy rating on Haleon PLC (HLN – Research Report), with a price target of £4.00. The company’s shares closed yesterday at p369.60.